Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
  • 0 views
  • 20 Sep, 2022
  • 1 location
Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC

To evaluate the safety and feasibility of pre-operative SABR of RCC IVC tumor thrombus. To evaluate the effect of pre-operative SABR in RCC IVC tumor thrombus on relapse free survival at

cancer
kidney tumor
kidney cancer
metastasis
tubal ligation
  • 8 views
  • 29 Jul, 2022
  • 1 location
  • 0 views
  • 27 Jan, 2021
  • 1 location
Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

To explore the efficacy of radiotherapy plus toripalimab Versus standard treatment of sorafenib in advanced hepatocellular carcinoma with Portal Vein/Hepatic vein Tumor Thrombosis.

  • 0 views
  • 18 Mar, 2021
  • 1 location
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

To compare the impact on survival of neo-adjuvant TAI for patients with HCC and PVTT who underwent hepatectomy.

thrombosis
calcium
metastasis
hepatectomy
neutrophil count
  • 4 views
  • 23 Feb, 2022
  • 1 location
HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

hepatocellular carcinoma and portal vein tumor thrombus.

  • 0 views
  • 26 Jan, 2021
  • 1 location
HAIC Combine With Lenvatinib and Camrelizumab for Advanced HCC With PVTT

advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT).

oxaliplatin
fluorouracil
  • 0 views
  • 22 Mar, 2022
TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

with TACE combined with sorafenib/lenvatinib (TACE-MKI) for hepatocellular carcinoma (HCC) with portal vein branch tumor thrombus (branch PVTT).

  • 0 views
  • 13 Aug, 2021
  • 1 location
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random Controlled Stage III Clinical Trial.

To compare the impact on recurrence risk of adjuvant TAI and adjuvant TACE for patients with HCC and PVTT after hepatectomy.

thrombosis
hepatectomy
TACE
chemoembolization
neutrophil count
  • 8 views
  • 21 Jan, 2021
Neo-TACE-HAIC for PVTT-HCC

Hepatocellular carcinoma (HCC) patients is a common disease in the East Asia. During the disease course, 20%-50% patients suffered portal vein tumor thrombus (PVTT), which is characterized with

liver cancer
cancer
chemoembolization
fluorouracil
tumour thrombus
  • 0 views
  • 26 Jan, 2021
  • 1 location